» Articles » PMID: 32143585

Furosemide Stress Test and Interstitial Fibrosis in Kidney Biopsies in Chronic Kidney Disease

Overview
Journal BMC Nephrol
Publisher Biomed Central
Specialty Nephrology
Date 2020 Mar 8
PMID 32143585
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Interstitial fibrosis (IF) on kidney biopsy is one of the most potent risk factors for kidney disease progression. The furosemide stress test (FST) is a validated tool that predicts the severity of acute kidney injury (especially at 2 h) in critically ill patients. Since furosemide is secreted through the kidney tubules, the response to FST represents the tubular secretory capacity. To our knowledge there is no data on the correlation between functional tubular capacity assessed by the FST with IF on kidney biopsies from patients with chronic kidney disease (CKD). The aim of this study was to determine the association between urine output (UO), Furosemide Excreted Mass (FEM) and IF on kidney biopsies after a FST.

Methods: This study included 84 patients who underwent kidney biopsy for clinical indications and a FST. The percentage of fibrosis was determined by morphometry technique and reviewed by a nephropathologist. All patients underwent a FST prior to the biopsy. Urine volume and urinary sodium were measured in addition to urine concentrations of furosemide at different times (2, 4 and 6 h). We used an established equation to determine the FEM. Values were expressed as mean, standard deviation or percentage and Pearson Correlation.

Results: The mean age of the participants was 38 years and 44% were male. The prevalence of diabetes mellitus, hypertension and diuretic use was significantly higher with more advanced degree of fibrosis. Nephrotic syndrome and acute kidney graft dysfunction were the most frequent indications for biopsy. eGFR was inversely related to the degree of fibrosis. Subjects with the highest degree of fibrosis (grade 3) showed a significant lower UO at first hour of the FST when compared to lower degrees of fibrosis (p = 0.015). Likewise, the total UO and the FEM was progressively lower with higher degrees of fibrosis. An inversely linear correlation between FEM and the degree of fibrosis (r = - 0.245, p = 0.02) was observed.

Conclusions: Our findings indicate that interstitial fibrosis correlates with total urine output and FEM. Further studies are needed to determine if UO and FST could be a non-invasive tool to evaluate interstitial fibrosis.

Trial Registration: ClinicalTrials.gov NCT02417883.

Citing Articles

Urine Uromodulin, Kidney Tubulointerstitial Fibrosis, and Furosemide Response.

Bullen A, Vaingankar S, Madero M, Lopez Gil S, Macedo E, Ix J Nephron. 2023; 148(7):443-447.

PMID: 38043509 PMC: 11216347. DOI: 10.1159/000534578.


Kidney Tubulointerstitial Fibrosis and Tubular Secretion.

Garimella P, Katz R, Waikar S, Srivastava A, Schmidt I, Hoofnagle A Am J Kidney Dis. 2021; 79(5):709-716.

PMID: 34571064 PMC: 8973399. DOI: 10.1053/j.ajkd.2021.08.015.


The Promise of Tubule Biomarkers in Kidney Disease: A Review.

Ix J, Shlipak M Am J Kidney Dis. 2021; 78(5):719-727.

PMID: 34051308 PMC: 8545710. DOI: 10.1053/j.ajkd.2021.03.026.


Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: a systemic review and meta-analysis.

Chen J, Chang C, Huang Y, Kuo G Crit Care. 2020; 24(1):202.

PMID: 32381019 PMC: 7206785. DOI: 10.1186/s13054-020-02912-8.


Role of the Furosemide Stress Test in Renal Injury Prognosis.

Coca A, Aller C, Reinaldo Sanchez J, Valencia A, Bustamante-Munguira E, Bustamante-Munguira J Int J Mol Sci. 2020; 21(9).

PMID: 32349337 PMC: 7247682. DOI: 10.3390/ijms21093086.

References
1.
Knight E, Verhave J, Spiegelman D, Hillege H, de Zeeuw D, Curhan G . Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004; 65(4):1416-21. DOI: 10.1111/j.1523-1755.2004.00517.x. View

2.
Alcorn D, Maric C, McCausland J . Development of the renal interstitium. Pediatr Nephrol. 1999; 13(4):347-54. DOI: 10.1007/s004670050624. View

3.
Mannon R, Matas A, Grande J, Leduc R, Connett J, Kasiske B . Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant. 2010; 10(9):2066-73. PMC: 2951299. DOI: 10.1111/j.1600-6143.2010.03240.x. View

4.
Ibrahim H, Mondress M, Tello A, Fan Y, Koopmeiners J, Thomas W . An alternative formula to the Cockcroft-Gault and the modification of diet in renal diseases formulas in predicting GFR in individuals with type 1 diabetes. J Am Soc Nephrol. 2005; 16(4):1051-60. DOI: 10.1681/ASN.2004080692. View

5.
Gowda S, Desai P, Kulkarni S, Hull V, Math A, Vernekar S . Markers of renal function tests. N Am J Med Sci. 2012; 2(4):170-3. PMC: 3354405. View